Proposed Data Collections Submitted for Public Comment and Recommendations, 43487 [E6-12307]
Download as PDF
<![CDATA[
43487
Federal Register / Vol. 71, No. 147 / Tuesday, August 1, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–06–0008]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Emergency Epidemic Investigations—
Extension—(0920–0008), Office of
Workforce and Career Development
(OWCD), Centers for Disease Control
and Prevention (CDC).
Background & Brief Description
The purpose of the Emergency
Epidemic Investigation surveillance is
to collect data on the conditions
surrounding and preceding the onset of
a problem. The data must be collected
in a timely fashion so that information
can be used to develop prevention and
control techniques, to interrupt disease
transmission and to help identify the
cause of an outbreak. The EPI-AID
mechanism is a means for Epidemic
Intelligence Service (EIS) officers of the
Centers for Disease Control and
Prevention (CDC), along with other CDC
staff, to provide technical support to
state health agencies requesting
assistance for epidemiologic field
investigations. This mechanism allows
CDC to respond rapidly to public health
problems in need of urgent attention,
thereby providing an important service
to state and other public health
agencies; and to provide supervised
training opportunities for EIS officers
(and, sometimes, other CDC trainees) to
actively participate in epidemiologic
investigations.
Epi Trip Reports are delivered to the
state health agency official requesting
assistance shortly after completion of
the EPI-AID investigation. This official
can comment on both the timeliness and
the practical utility of the
recommendations from the
investigation. Upon completion of the
EPI-AID investigation, requesting
officials at the state or local health
department will be asked to complete a
brief questionnaire to assess the
promptness of the investigation and the
usefulness of the recommendations.
There is no cost to the respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
No. of respondents
Requestors of EPI-AIDs .................
∼ 100 per year ...............................
Dated: July 26, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–12307 Filed 7–31–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Cardiovascular and Renal Drugs
Advisory Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
rwilkins on PROD1PC63 with NOTICES
No. of
responses per
respondent
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
VerDate Aug<31>2005
20:04 Jul 31, 2006
Jkt 208001
Average
burden per
response
(in hours)
1
Name of Committee: Cardiovascular
and Renal Drugs Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on September 21, 2006, from 8 a.m.
to 5 p.m.
Location: Food and Drug
Administration, CDER Advisory
Committee Conference Room, rm. 1066,
5630 Fishers Lane, Rockville, MD.
Contact Person: Cathy Groupe, Center
for Drug Evaluation and Research (HFD–
21), Food and Drug Administration,
5600 Fishers Lane (for express delivery,
5630 Fishers Lane, rm. 1093) Rockville,
MD 20857, 301–827–7001, FAX: 301–
827–6778, e-mail:
Cathy.Groupe@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512533. Please call the information
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
15/60
Total burden
(in hours)
25 hours per year
line for up-to-date information on this
meeting.
Agenda: The committee will discuss
clinical data for aprotinin injection
(trade name, TRASYOL), an approved
product, new drug application (NDA)
020–304, Bayer Pharmaceuticals) with
the indication for prophylactic use to
reduce perioperative blood loss and the
need for blood transfusion in patients
undergoing cardiopulmonary bypass in
the course of coronary artery bypass
graft surgery. This discussion follows a
February 8, 2006, FDA Public Health
Advisory for the use of apportioning
injection (www.fda.gov/cder/drug/
advisory/aprotinin.htm). The
background material for this meeting
will be posted 1 business day before the
meeting on FDA’s Website at https://
www.fda.gov/ohrms/dockets/ac/
acmenu.htm under the heading
‘‘Cardiovascular and Renal Drugs
Advisory Committee.’’ (Click on the
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 71, Number 147 (Tuesday, August 1, 2006)]
[Notices]
[Page 43487]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12307]
[[Page 43487]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-06-0008]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Emergency Epidemic Investigations--Extension--(0920-0008), Office
of Workforce and Career Development (OWCD), Centers for Disease Control
and Prevention (CDC).
Background & Brief Description
The purpose of the Emergency Epidemic Investigation surveillance is
to collect data on the conditions surrounding and preceding the onset
of a problem. The data must be collected in a timely fashion so that
information can be used to develop prevention and control techniques,
to interrupt disease transmission and to help identify the cause of an
outbreak. The EPI-AID mechanism is a means for Epidemic Intelligence
Service (EIS) officers of the Centers for Disease Control and
Prevention (CDC), along with other CDC staff, to provide technical
support to state health agencies requesting assistance for
epidemiologic field investigations. This mechanism allows CDC to
respond rapidly to public health problems in need of urgent attention,
thereby providing an important service to state and other public health
agencies; and to provide supervised training opportunities for EIS
officers (and, sometimes, other CDC trainees) to actively participate
in epidemiologic investigations.
Epi Trip Reports are delivered to the state health agency official
requesting assistance shortly after completion of the EPI-AID
investigation. This official can comment on both the timeliness and the
practical utility of the recommendations from the investigation. Upon
completion of the EPI-AID investigation, requesting officials at the
state or local health department will be asked to complete a brief
questionnaire to assess the promptness of the investigation and the
usefulness of the recommendations. There is no cost to the respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
No. of burden per Total burden (in
Respondents No. of respondents responses per response (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Requestors of EPI-AIDs............ ~ 100 per year....... 1 15/60 25 hours per year
----------------------------------------------------------------------------------------------------------------
Dated: July 26, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-12307 Filed 7-31-06; 8:45 am]
BILLING CODE 4163-18-P
